Duke University
|
Grant Number:
|
1U01AR057965-01
|
|
Project Title:
|
Validating and Extending the PROMIS Sexual Function Measure for Clinical Research
|
|
PI Name, Title and Contact Information:
|
Kevin Weinfurt, PhD, Principal Investigator
Associate Professor of Psychiatry and Behavioral Sciences, and Associate Professor,
Department of Psychology and Neuroscience, Duke University
|
|
Other Key Personnel:
|
Carrie Dombeck, Project Manager
Amy Abernethy, MD, Co-investigator
Ann Brown, MD, Co-investigator
Deborah Bruner, PhD, Co-investigator
Jill Cyranowski, PhD, Consortium PI
Mark Feinglos, MD, Consortium PI
Kathryn Flynn, PhD, Co-investigator
Adrian Hernandez, MD, Co-investigator
John Willse, PhD, Consortium PI
|
|
Web Site:
|
http://www.dcri.duke.edu
|
Abstract:
The National Institutes of Health (NIH) established the Patient-Reported Outcomes
Measurement Information System (PROMIS) Network with the goal of developing a comprehensive,
standardized, and efficient means of measuring patient–reported outcomes in
persons with chronic diseases. As one of the 7 original research sites, Duke University
led the development of 2 domains of measurement for patients with cancer, including
sexual function. Sexual function and satisfaction are strong determinants of overall
quality of life and are affected by many chronic diseases and their treatments.
Yet little work has been done to measure sexual function across chronic diseases
using consistent, high quality measurement approaches. The first phase of PROMIS
supported research toward the development of the sexual function domain for cancer
populations. Early testing suggests the PROMIS measure is superior to many alternatives
in terms of understandability, comprehensiveness, and appropriateness for many types
of people. In the next phase of PROMIS, we wish to broaden the applicability of
the measure to chronic diseases beyond cancer. The work proposed in this application
will ensure that the initial investment by NIH in the PROMIS sexual function domain
will result in a measure that is useful across therapeutic areas and meets all of
the PROMIS standards. The proposed work will advance the development of the sexual
function domain by pursuing 4 Specific Aims.
AIM 1: To assess the validity (including responsiveness) of the
PROMIS sexual function measure in men and women undergoing treatment for prostate
or gynecologic cancers.
AIM 2: To evaluate and ensure the appropriateness of the PROMIS
sexual function measure in patients with heart failure, diabetes mellitus, and mood
and anxiety disorders.
AIM 3: To collect and analyze responses to the PROMIS sexual function
measure from a nationally representative sample of the US population.
AIM 4: To produce a Spanish–language version of the PROMIS
sexual function measure.
Patient Populations/Disease Groups
Patients undergoing treatment for prostate or gynecologic cancers (Aim 1); patients
with heart failure, diabetes mellitus, and mood and anxiety disorders (Aim 2); and
a nationally representative US sample (Aim 3).
For questions concerning Duke's role in the PROMIS network, please contact Kevin
Weinfurt, PhD, by e-mail at kevin.weinfurt@duke.edu.
For more information about the PROMIS network, go to
http://www.nihpromis.org.